AJANTPHARM.NS Trace Score
Computed from 3 of 4 components — see the breakdown below for which were unavailable.
A description of what's already in these four filed signals, not a rating, recommendation, or forecast. Each component below is computed and cited exactly where it already lives in the app — this page only combines them, with equal weight per component.
Fundamentals Momentum
3 / 9 met
3 of 9 computable Piotroski criteria met (9 of 9 total computable).
Growth Consistency
1 / 1 met
1 of 1 growth checks positive (5y or best available shorter span).
Earnings Quality
not included in the composite
Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.
Sector Standing
3 / 3 inputs available
Mean sector percentile across ROE, ROCE, Debt/Equity (3 of 3 available).
The composite is the equal-weighted mean of whichever of the four components could be computed — never a fixed denominator, so an unavailable component re-weights the rest rather than counting as zero (the same principle Piotroski uses among its own criteria). A minimum of 2 of 4 components must be computable before any number is shown at all. Equal weight is per component, not per underlying criterion: Piotroski's 9 sub-criteria versus Growth's 2 is an accident of an external methodology, not a StockProof judgement about relative importance. Margin Trend and ROCE Trajectory are shown on the detail page but excluded here (they restate what Piotroski's own criteria already test); P/E is excluded as a valuation signal, not a quality one.